BANK VONTOBEL/PUT/SANOFI/76/0.1/20.12.24 Share Price

Warrant

DE000VM70829

Market Closed - Boerse Frankfurt Warrants 11:11:40 01/07/2024 pm IST
0.11 EUR -14.73% Intraday chart for BANK VONTOBEL/PUT/SANOFI/76/0.1/20.12.24
Current month-14.73%
1 month-15.38%
Date Price Change
01/24/01 0.11 -14.73%
28/24/28 0.129 -11.03%
27/24/27 0.145 +12.40%
26/24/26 0.129 +6.61%
25/24/25 0.121 -8.33%

Real-time Boerse Frankfurt Warrants

Last update July 01, 2024 at 11:11 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying SANOFI
IssuerLogo Issuer Vontobel Vontobel
WKN VM7082
ISINDE000VM70829
Date issued 05/01/2024
Strike 76
Maturity 20/12/2024 (172 Days)
Parity 10 : 1
Emission price 0.23
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.37
Lowest since issue 0.102
Spread 0.014
Spread %11.29%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
91.85 EUR
Average target price
107.9 EUR
Spread / Average Target
+17.43%
Consensus